MiniMed's Continuous Blood Glucose Monitoring system (CGMS) was just recommended for approval by an FDA panel. Are you interested in using it?
Poll dates: February 28 - March 7, 1999
Total Votes: 508
MiniMed's Continuous Blood Glucose Monitoring system (CGMS) represents a potential revolution in blood sugar monitoring. Multiple finger-stick blood tests cannot provide a complete picture of the daily high and low blood sugars that people with diabetes experience. Only a continuous monitor can do that. As the first such product recommended for FDA approval, the CGMS will provide most people with the first look at what their daily blood sugars really are.
In it's present form, the CGMS will only provide a retrospective look at three days of blood sugar values. That data will provide you and your health care team with better insight into your diabetes management needs, and could help you make adjustments to your care.
[Return to the current poll]
Last Updated: Wednesday March 16, 2005 16:36:16
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.